HLA-DRB1 and myeloid sarcoma: Consistent with our previous observations [51,52], carriers of at least one copy of the major MS risk allele HLA-DRB1*15:01 were significantly overrepresented in the MS group compared to controls (51.5% vs. 20.1%; p < 0.0001).